For people with advanced bladder cancer, surgically removing the bladder can cure the disease, but it is a risky procedure that can also affect quality of life. Arjun V. Balar, MD, associate professor in the Department of Medicine and director of the Genitourinary Medical Oncology Program at NYU Langone Health’s Perlmutter Cancer Center, discusses using immunotherapies to treat bladder cancer, the role of clinical trials in advancing treatment, and more.
“I tell patients all the time that the best treatments in cancer are not from 10 years ago, 5 years ago, or, heck, even 2 or 3 years ago. The best treatments in cancer are now,” Dr. Balar tells The CRI Blog. “In general, the best access to new treatments is through trials, and very often a patient’s best treatment option is a clinical trial.”
Read more from The CRI Blog.